May 27, 2026
John Boozman- Amount
- $1,001 to $15,000
- Filed
- Jun 16, 2026
Congress ticker disclosure profile
As of August 1 at 2:20 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference GBIL. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
1
Feed lifetime
18
Member filers
2
Disclosed ranges
$32K
Most active member desks
10 buys vs 8 sells
Latest trade May 27, 2026
May 27, 2026
John BoozmanSep 16, 2025
John BoozmanJan 17, 2024
Thomas R. CarperDec 12, 2023
John BoozmanNov 7, 2023
John BoozmanFeb 15, 2023
Thomas R. CarperNov 29, 2022
Thomas R. CarperNov 15, 2022
Thomas R. CarperNov 8, 2022
Thomas R. CarperJan 26, 2022
Thomas R. CarperJan 18, 2022
Thomas R. CarperJul 26, 2021
Thomas R. CarperNov 20, 2020
Thomas R. CarperAug 21, 2020
Thomas R. CarperAug 6, 2020
Thomas R. CarperJul 9, 2020
Thomas R. CarperJul 7, 2020
Thomas R. CarperApr 2, 2020
Thomas R. Carper| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| May 27, 2026 | John Boozman | Buy | $1,001 to $15,000 | Jun 16, 2026 | Open card |
| Sep 16, 2025 | John Boozman | Sell | $1,001 to $15,000 | Oct 10, 2025 | Open card |
| Jan 17, 2024 | Thomas R. Carper | Buy | Receipt pending ingestion | Feb 2, 2024 | Receipt pending ingestion |
| Dec 12, 2023 | John Boozman | Sell | $1,001 to $15,000 | Jan 8, 2024 | Open card |
| Nov 7, 2023 | John Boozman | Sell | $1,001 to $15,000 | Dec 12, 2023 | Open card |
| Feb 15, 2023 | Thomas R. Carper | Buy | Receipt pending ingestion | Mar 1, 2023 | Receipt pending ingestion |
| Nov 29, 2022 | Thomas R. Carper | Buy | Receipt pending ingestion | Dec 9, 2022 | Receipt pending ingestion |
| Nov 15, 2022 | Thomas R. Carper | Buy | Receipt pending ingestion | Dec 9, 2022 | Receipt pending ingestion |
| Nov 8, 2022 | Thomas R. Carper | Buy | Receipt pending ingestion | Dec 9, 2022 | Receipt pending ingestion |
| Jan 26, 2022 | Thomas R. Carper | Sell | Receipt pending ingestion | Feb 3, 2022 | Receipt pending ingestion |
| Jan 18, 2022 | Thomas R. Carper | Sell | Receipt pending ingestion | Feb 3, 2022 | Receipt pending ingestion |
| Jul 26, 2021 | Thomas R. Carper | Buy | Receipt pending ingestion | Aug 2, 2021 | Receipt pending ingestion |
| Nov 20, 2020 | Thomas R. Carper | Buy | Receipt pending ingestion | Dec 2, 2020 | Receipt pending ingestion |
| Aug 21, 2020 | Thomas R. Carper | Sell | Receipt pending ingestion | Sep 1, 2020 | Receipt pending ingestion |
| Aug 6, 2020 | Thomas R. Carper | Sell | Receipt pending ingestion | Sep 1, 2020 | Receipt pending ingestion |
| Jul 9, 2020 | Thomas R. Carper | Buy | Receipt pending ingestion | Aug 4, 2020 | Receipt pending ingestion |
| Jul 7, 2020 | Thomas R. Carper | Buy | Receipt pending ingestion | Aug 4, 2020 | Receipt pending ingestion |
| Apr 2, 2020 | Thomas R. Carper | Sell | Receipt pending ingestion | May 4, 2020 | Receipt pending ingestion |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 4 of 18 filed rows include disclosed amount ranges (22%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.